Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets

被引:88
|
作者
Moss, Joe W. E. [1 ]
Ramji, Dipak P. [1 ]
机构
[1] Cardiff Univ, Cardiff Sch Biosci, Sir Martin Evans Bldg,Museum Ave, Cardiff CF10 3AX, S Glam, Wales
关键词
atherosclerosis; cardiovascular disease; chemokines; cytokines; foam cells; inflammation; nanoparticles; neutralization; NF-KAPPA-B; C-REACTIVE PROTEIN; EICOSAPENTAENOIC ACID; CARDIOVASCULAR-DISEASE; CHEMOKINE RECEPTOR; PHARMACOLOGICAL INHIBITION; REDUCES ATHEROSCLEROSIS; DOCOSAHEXAENOIC ACID; SCAVENGER RECEPTORS; HUMAN MACROPHAGES;
D O I
10.4155/fmc-2016-0072
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Atherosclerosis, the primary cause of cardiovascular disease (CVD), is a chronic inflammatory disorder in the walls of medium and large arteries. CVD is currently responsible for about one in three global deaths and this is expected to rise in the future due to an increase in the prevalence of obesity and diabetes. Current therapies for atherosclerosis mainly modulate lipid homeostasis and while successful at reducing the risk of a CVD-related death, they are associated with considerable residual risk and various side effects. There is, therefore, a need for alternative therapies aimed at regulating inflammation in order to reduce atherogenesis. This review will highlight the key role cytokines play during disease progression as well as potential therapeutic strategies to target them.
引用
收藏
页码:1317 / 1330
页数:14
相关论文
共 50 条
  • [1] Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
    Ramji, Dipak P.
    Davies, Thomas S.
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2015, 26 (06) : 673 - 685
  • [2] Chemokines as potential therapeutic targets in atherosclerosis
    Sheikine, YA
    Hansson, GK
    [J]. CURRENT DRUG TARGETS, 2006, 7 (01) : 13 - 28
  • [3] Roles of c-Met and RON Kinases in tumor progression and their potential as therapeutic targets
    Chang, Katherine
    Karnad, Anand
    Zhao, Shujie
    Freeman, James W.
    [J]. ONCOTARGET, 2015, 6 (06) : 3507 - 3518
  • [4] Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
    Yu, Zemou
    Peng, Qing
    Huang, Yining
    [J]. CLINICAL SCIENCE, 2019, 133 (06) : 763 - 776
  • [5] Cytokines as therapeutic agents and targets in heart disease
    Dubnika, Arita
    Manoukian, Martin A. C.
    Mohammadi, M. Rezaa
    Parekh, Mansi Bharat
    Gurjarpadhye, Abhijit Achyut
    Inayathullah, Mohammed
    Dubniks, Viktors
    Lakey, Jonathan R. T.
    Rajadas, Jayakumar
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2018, 43 : 54 - 68
  • [6] Roles of PPARs in NAFLD: Potential therapeutic targets
    Tailleux, Anne
    Wouters, Kristiaan
    Staels, Bart
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2012, 1821 (05): : 809 - 818
  • [7] Cytokines in Sjogren's syndrome: potential therapeutic targets
    Roescher, Nienke
    Tak, Paul P.
    Illei, Gabor G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) : 945 - 948
  • [8] Cytokines as potential therapeutic targets for inflammatory skin diseases
    Numerof, RP
    Dinarello, CA
    Asadullah, K
    [J]. EUROPEAN CYTOKINE NETWORK, 2005, 16 (02) : 101 - 103
  • [9] Exploring immune checkpoints as potential therapeutic targets in atherosclerosis
    Kusters, Pascal J. H.
    Lutgens, Esther
    Seijkens, Tom T. P.
    [J]. CARDIOVASCULAR RESEARCH, 2018, 114 (03) : 368 - 377
  • [10] Liver X Receptors as potential therapeutic targets in atherosclerosis
    Zhu, Yanfei
    Li, Yousheng
    [J]. CLINICAL AND INVESTIGATIVE MEDICINE, 2009, 32 (05): : E383 - E394